Skip Navigation

Research Funding

Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Sample Applications and Summary Statements

Table of Contents

Introduction

Several investigators have graciously agreed to let us post their exceptional applications online.

We are truly indebted to the investigators listed below, who have enabled us to deliver this widely anticipated resource to the research community.

We selected these applications as sound examples of good grantsmanship, which we highlighted with annotations.

NB. The text of these applications is copyrighted. You may use it only for nonprofit educational purposes provided the document remains unchanged and the PI, the grantee organization, and NIAID are credited.

How to Print the Files

Depending on your local printer settings, you may need to adjust margins or page layout to print the full page.

R01 Sample Applications and Summary Statements

PI and Grantee Institution Application Resources
Colin Parrish, Ph.D., of Cornell University
"Structural controls of functional receptor and antibody binding to viral capsids"
Summary Statement
Research Plan
Full Application
Adam Ratner, M.D., M.P.H., of Columbia University
"Gardnerella vaginalis: toxin production and pathogenesis"
Summary Statement
Research Plan
Full Application
Boris Striepen, Ph.D., of the University of Georgia
"Biology of the apicomplexan plastid"
Summary Statement
Research Plan
Full Application
Carolina Wählby, Ph.D., of the Broad Institute
"Image analysis for high-throughput C. elegans infection and metabolism assays"
Summary Statement
Research Plan
Full Application

R21 Sample Applications and Summary Statements

Please note that the R21 funds novel scientific ideas, model systems, tools, agents, targets, and technologies that have the potential to substantially advance biomedical research. R21s are not intended for new investigators, and there is no evidence that they provide a path to an independent research career.

PI and Grantee Institution Application Resources
Steven W. Dow, DVM, Ph.D., of Colorado State University, Fort Collins
"Mechanisms of enteric Burkholderia psuedomallei infection"
Summary Statement
Full Application
Joseph M. McCune, MD, Ph.D., of the University of California, San Francisco
"Human immune system layering and the neonatal response to vaccines"
Summary Statement
Full Application
Peter John Myler, Ph.D., and Marilyn Parsons, Ph.D., of the Seattle Biomedical Research Institute
"Ribosome profiling of Trypanosoma brucei"
Summary Statement
Full Application
Howard T. Petrie, of Scripps Florida
"Lymphoid signals for stromal growth and organization in the thymus."
Summary Statement
Full Application
Michael N. Starnbach, Ph.D., of Harvard University Medical School
"Alteration of host protein stability by Legionella"
Summary Statement
Full Application

R21/R33 Sample Application and Summary Statement

The R21/R33 supports a two-phased award without a break in funding. It begins with the R21 phase for milestone-driven exploratory or feasibility studies with a possible transition to the R33 phase for expanded development. Transition to the second phase depends on several factors, including the achievement of negotiated milestones.

PI and Grantee Institution Application Resources
Stephen Dewhurst, Ph.D., of the University of Rochester
"The semen enhancer of HIV infection as a novel microbicide target"
Summary Statement
Full Application

R43/R44 Sample Application and Summary Statement

The R43/R44 supports domestic small businesses to engage in research and development with the potential for commercialization.

PI and Grantee Institution Application Resources
Michael J. Lochhead of MBio Diagnostics, Inc.
"Point-of-Care HIV Angigen/Antibody Diagnostic Device"
Full Application

F31-Diversity Sample Applications and Summary Statements

The F31-Diversity supports predoctoral students from underrepresented racial and ethnic groups, those with disabilities, and those from disadvantaged backgrounds. It also provides individualized, mentored research training from outstanding faculty sponsors.

PI and Grantee Institution Application Resources
Adjoa R. Smalls-Mantey of Columbia University Health Sciences
"Characterization of Antibody-Dependent Cellular Cytotoxicity in HIV Infection"
Summary Statement and Full Application
Juan Calix of University of Alabama at Birmingham
"The role of wcjE disruption in pneumococcal serotype 11A humoral escape"
Summary Statement and Full Application

Links to Other Samples and More Resources

For information about preparing the forms and page limits:

Contact Us

If you have knowledge to share or want more information on this topic, email deaweb@niaid.nih.gov with this link and your message. Thanks for helping us clarify and expand our knowledge base.

Last Updated October 28, 2014

Last Reviewed October 03, 2014